Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Radiation Injuries 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1

Interventions

Docetaxel 8Radiotherapy 6Filgrastim 4Bevacizumab 4Paclitaxel 3Nivolumab 3Magnetic Resonance Spectroscopy 3Erlotinib Hydrochloride 3Cisplatin 3Cetuximab 3Carboplatin 3Capecitabine 3regorafenib 2pembrolizumab 2Radiotherapy, Intensity-Modulated 2Gemcitabine 2Cyclophosphamide 2Chemotherapy, Adjuvant 2Biopsy 2Acupuncture Therapy 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tanespimycin 1spartalizumab 1sargramostim 1oncogene protein E7, Human papillomavirus type 16 1oblimersen 1fluoromisonidazole 1fludarabine phosphate 1etoposide phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × cevimeline × CNS × Clear all
NCT00017511 2012-05-16

Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer

Daiichi Sankyo

Phase 3 Completed
CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡